Anti-citrullinated protein antibodies (ACPAs), the hallmark biomarkers of RA, have been shown to stimulate NLRP3 inflammasome assembly and promote IL-1β secretion in immune cells derived from RA patients [7]. This evidence concerns the gene NLRP3 and rheumatoid arthritis.